Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) Stock Price, Quote & AI Analysis

Live MRVI stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Maravai LifeSciences Holdings, Inc. Class A Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.170000
High
3.210000
Low
3.070000
Volume
702,763
VWAP
-
Market Cap
$495,977,808.42
52W Range
$1.67 - $5.03
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 16, 2026 Q4
After Hours
EPS Estimate: $-0.0723
Revenue Estimate: $50,026,369.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Maravai LifeSciences Holdings, Inc. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Maravai LifeSciences Holdings, Inc. Class A Common Stock Overview

Company information

Company Overview

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Company Details
Market Cap
$805.48M
Shares Outstanding
255,706,749
Weighted Shares Outstanding
145,022,751
CEO
Bernd Brust
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA, 92121
Employees
550
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Maravai LifeSciences Holdings, Inc. Class A Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...